AstraZeneca PLC (Germany) Top Insiders

AstraZeneca PLC Management Team Effectiveness

The company has return on total asset (ROA) of 0.0788 % which means that it generated a profit of $0.0788 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2284 %, meaning that it generated $0.2284 on every $100 dollars invested by stockholders. AstraZeneca PLC's management efficiency ratios could be used to measure how well AstraZeneca PLC manages its routine affairs as well as how well it operates its assets and liabilities. The current Total Assets is estimated to decrease to about 87.5 B. The current Net Tangible Assets is estimated to decrease to about (20.9 B)The AstraZeneca PLC's current Common Stock Shares Outstanding is estimated to increase to about 1.6 B, while Net Income Applicable To Common Shares is projected to decrease to roughly 1.8 B. AstraZeneca PLC holds a total of 1.55 Billion outstanding shares. Almost 73.34 percent of AstraZeneca PLC outstanding shares are held by general public with 0.02 (percent) owned by insiders and only 26.65 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it. Some institutional investors establish a significant position in stocks such as AstraZeneca PLC in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of AstraZeneca PLC, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

AstraZeneca PLC Workforce Comparison

The company has Profit Margin (PM) of 0.17 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.18 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.18.

AstraZeneca PLC Benchmark Summation

AstraZeneca PLC Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as AstraZeneca PLC often depends on how effective the management is. AstraZeneca PLC management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of AstraZeneca management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the AstraZeneca management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

When running AstraZeneca PLC's price analysis, check to measure AstraZeneca PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AstraZeneca PLC is operating at the current time. Most of AstraZeneca PLC's value examination focuses on studying past and present price action to predict the probability of AstraZeneca PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AstraZeneca PLC's price. Additionally, you may evaluate how the addition of AstraZeneca PLC to your portfolios can decrease your overall portfolio volatility.